Search Results
You are looking at 1 - 1 of 1 items for
- Author: Marilie D Gammon x
- Refine by access: All content x
Search for other papers by Vasily N Aushev in
Google Scholar
PubMed
Search for other papers by Kalpana Gopalakrishnan in
Google Scholar
PubMed
Search for other papers by Susan L Teitelbaum in
Google Scholar
PubMed
Search for other papers by Humberto Parada Jr in
Google Scholar
PubMed
Search for other papers by Regina M Santella in
Google Scholar
PubMed
Search for other papers by Marilie D Gammon in
Google Scholar
PubMed
Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Search for other papers by Jia Chen in
Google Scholar
PubMed
Environmental phenols and phthalates are common ingredients in personal care products and some have been implicated in breast cancer progression. We have previously identified genes differentially expressed in response to low-dose exposure to diethyl phthalate (DEP) and methyl paraben (MPB) in a rat model. Herein we explore if these genes are associated with breast cancer mortality in humans. We profiled MPB- and DEP-responsive genes in tumors by NanoString® from a population-based cohort of 606 women with first primary breast cancer among whom 119 breast cancer-specific deaths occurred within 15+ years of follow-up. For each gene, Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Results were validated in two publicly available datasets. The following results were obtained. From 107 DEP- and 77 MPB-responsive genes profiled, 44 and 30 genes, respectively, were significantly associated with breast cancer-specific mortality. Some top DEP-responsive genes are novel for breast cancer mortality, such as ABHD14B (for high-vs-low expression, HR 0.36, 95% CI: 0.2–0.5) and TMC4 (HR 0.37, 95% CI: 0.3–0.5); top hits for MPB (SLC40A1 (HR 0.37, 95% CI: 0.3–0.5) and NTN4 (HR 0.39, 95% CI: 0.3–0.6)) are well-known predictors of breast cancer survival. PLEKHA6 was another novel survival predictor, sensitive to hormonal receptor status (HR 0.5, 95% CI 0.3–0.9 for hormonal receptor-positive and HR 3.2, 95% CI 1.7–6.2 for -negative group). In conclusion, tumor expression of DEP- and MPB-responsive genes is associated with breast cancer mortality, supporting that exposure to these chemicals may influence the progression of breast cancer.